Allarity Therapeutics obtains $20M debt financing from Streeterville Capital with $20.93M notes

Allarity Therapeutics, Inc.

• Issued $10.93M A-1 Note (9% interest) and $10M secured B Note (5% interest) for $20M purchase price.
• $900K OID and $30K expense included; maturity 18 months from March 2, 2026.
• B Note secured by $10M deposit account and pledge of ALLR Holdings LLC; guaranteed by three subsidiaries.
• Covenants restrict additional debt, variable-rate issuances, and asset encumbrances without lender consent.
• Investor can redeem up to $250K/month starting 6 months after closing; trigger events allow 10%/5% balance increases.